STAT signaling in the pathogenesis and treatment of myeloid malignancies
MetadataShow full item record
CitationBar-Natan, Michal, Erik A. Nelson, Michael Xiang, and David A. Frank. 2012. “STAT signaling in the pathogenesis and treatment of myeloid malignancies.” JAK-STAT 1 (2): 55-64. doi:10.4161/jkst.20006. http://dx.doi.org/10.4161/jkst.20006.
AbstractSTAT transcription factors play a critical role in mediating the effects of cytokines on myeloid cells. As STAT target genes control key processes such as survival, proliferation and self-renewal, it is not surprising that constitutive activation of STATs, particularly STAT3 and STAT5, are common events in many myeloid tumors. STATs are activated both by mutant tyrosine kinases as well as other pathogenic events, and continued activation of STATs is common in the setting of resistance to kinase inhibitors. Thus, the targeting of STATs, alone or in combination with other drugs, will likely have increasing importance for cancer therapy.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11877093
- HMS Scholarly Articles